Adam Blau is a highly experienced research professional currently serving as a Research Associate II at PineTree Therapeutics Inc since June 2024. Prior experience includes roles at Biocytogen as an Associate Scientist I from January 2021 to May 2024, where support was provided for In Vivo Pharmacology, and multiple positions in the Antibody Discovery department, including Senior Research Associate II, Senior Research Associate I, and Research Associate II. Adam's earlier career involved technical research at Harvard Medical School, focusing on nanoparticles for stem cell therapies, and contributions as a research intern at Neural Stem Cell Institute, developing a stem cell line for frontotemporal dementia studies. Academic credentials include a Master of Science in Biomedical Sciences from the University at Albany and a Bachelor's Degree in Psychology from the University of Connecticut.